Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells

Samer Hasan Hussein Al Ali,1 Mothanna Al-Qubaisi,2 Mohd Zobir Hussein,1,3 Maznah Ismail,2,4 Zulkarnain Zainal,1 Muhammad Nazrul Hakim51Department of Chemistry, Faculty of Science, 2Laboratory of Molecular Biomedicine, Institute of Bioscience, 3Advanced Materials and Nanotechnology Laboratory, Instit...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Hussein Al Ali SH, Al-Qubaisi M, Hussein MZ, Ismail M, Zainal Z, Hakim MN
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2012
Materias:
Acceso en línea:https://doaj.org/article/93412423e2864ec299490f599a67cef7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:93412423e2864ec299490f599a67cef7
record_format dspace
spelling oai:doaj.org-article:93412423e2864ec299490f599a67cef72021-12-02T01:43:42ZControlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells1176-91141178-2013https://doaj.org/article/93412423e2864ec299490f599a67cef72012-07-01T00:00:00Zhttp://www.dovepress.com/controlled-release-formulation-of-antihistamine-based-on-cetirizine-zi-a10285https://doaj.org/toc/1176-9114https://doaj.org/toc/1178-2013Samer Hasan Hussein Al Ali,1 Mothanna Al-Qubaisi,2 Mohd Zobir Hussein,1,3 Maznah Ismail,2,4 Zulkarnain Zainal,1 Muhammad Nazrul Hakim51Department of Chemistry, Faculty of Science, 2Laboratory of Molecular Biomedicine, Institute of Bioscience, 3Advanced Materials and Nanotechnology Laboratory, Institute of Advanced Technology (ITMA), 4Department of Nutrition and Dietetics, Faculty of Medicine and Health Science, Universiti Putra, Malaysia; 5Department of Biomedical Science, Faculty of Medicine and Health Science, Universiti Putra Malaysia, Selangor, MalaysiaAbstract: A controlled-release formulation of an antihistamine, cetirizine, was synthesized using zinc-layered hydroxide as the host and cetirizine as the guest. The resulting well-ordered nanolayered structure, a cetirizine nanocomposite "CETN," had a basal spacing of 33.9 Å, averaged from six harmonics observed from X-ray diffraction. The guest, cetirizine, was arranged in a horizontal bilayer between the zinc-layered hydroxide (ZLH) inorganic interlayers. Fourier transform infrared spectroscopy studies indicated that the intercalation takes place without major change in the structure of the guest and that the thermal stability of the guest in the nanocomposites is markedly enhanced. The loading of the guest in the nanocomposites was estimated to be about 49.4% (w/w). The release study showed that about 96% of the guest could be released in 80 hours by phosphate buffer solution at pH 7.4 compared with about 97% in 73 hours at pH 4.8. It was found that release was governed by pseudo-second order kinetics. Release of histamine from rat basophilic leukemia cells was found to be more sensitive to the intercalated cetirizine in the CETN compared with its free counterpart, with inhibition of 56% and 29%, respectively, at 62.5 ng/mL. The cytotoxicity assay toward Chang liver cells line show the IC50 for CETN and ZLH are 617 and 670 µg/mL, respectively.Keywords: cetirizine hydrochloric acid, nanocomposite, zinc-layered hydroxide, histamine release, rat basophilic leukemia (RBL-2H3) cellsHussein Al Ali SHAl-Qubaisi MHussein MZIsmail MZainal ZHakim MNDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2012, Iss default, Pp 3351-3363 (2012)
institution DOAJ
collection DOAJ
language EN
topic Medicine (General)
R5-920
spellingShingle Medicine (General)
R5-920
Hussein Al Ali SH
Al-Qubaisi M
Hussein MZ
Ismail M
Zainal Z
Hakim MN
Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells
description Samer Hasan Hussein Al Ali,1 Mothanna Al-Qubaisi,2 Mohd Zobir Hussein,1,3 Maznah Ismail,2,4 Zulkarnain Zainal,1 Muhammad Nazrul Hakim51Department of Chemistry, Faculty of Science, 2Laboratory of Molecular Biomedicine, Institute of Bioscience, 3Advanced Materials and Nanotechnology Laboratory, Institute of Advanced Technology (ITMA), 4Department of Nutrition and Dietetics, Faculty of Medicine and Health Science, Universiti Putra, Malaysia; 5Department of Biomedical Science, Faculty of Medicine and Health Science, Universiti Putra Malaysia, Selangor, MalaysiaAbstract: A controlled-release formulation of an antihistamine, cetirizine, was synthesized using zinc-layered hydroxide as the host and cetirizine as the guest. The resulting well-ordered nanolayered structure, a cetirizine nanocomposite "CETN," had a basal spacing of 33.9 Å, averaged from six harmonics observed from X-ray diffraction. The guest, cetirizine, was arranged in a horizontal bilayer between the zinc-layered hydroxide (ZLH) inorganic interlayers. Fourier transform infrared spectroscopy studies indicated that the intercalation takes place without major change in the structure of the guest and that the thermal stability of the guest in the nanocomposites is markedly enhanced. The loading of the guest in the nanocomposites was estimated to be about 49.4% (w/w). The release study showed that about 96% of the guest could be released in 80 hours by phosphate buffer solution at pH 7.4 compared with about 97% in 73 hours at pH 4.8. It was found that release was governed by pseudo-second order kinetics. Release of histamine from rat basophilic leukemia cells was found to be more sensitive to the intercalated cetirizine in the CETN compared with its free counterpart, with inhibition of 56% and 29%, respectively, at 62.5 ng/mL. The cytotoxicity assay toward Chang liver cells line show the IC50 for CETN and ZLH are 617 and 670 µg/mL, respectively.Keywords: cetirizine hydrochloric acid, nanocomposite, zinc-layered hydroxide, histamine release, rat basophilic leukemia (RBL-2H3) cells
format article
author Hussein Al Ali SH
Al-Qubaisi M
Hussein MZ
Ismail M
Zainal Z
Hakim MN
author_facet Hussein Al Ali SH
Al-Qubaisi M
Hussein MZ
Ismail M
Zainal Z
Hakim MN
author_sort Hussein Al Ali SH
title Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells
title_short Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells
title_full Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells
title_fullStr Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells
title_full_unstemmed Controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (RBL-2H3) cells
title_sort controlled-release formulation of antihistamine based on cetirizine zinc-layered hydroxide nanocomposites and its effect on histamine release from basophilic leukemia (rbl-2h3) cells
publisher Dove Medical Press
publishDate 2012
url https://doaj.org/article/93412423e2864ec299490f599a67cef7
work_keys_str_mv AT husseinalalish controlledreleaseformulationofantihistaminebasedoncetirizinezinclayeredhydroxidenanocompositesanditseffectonhistaminereleasefrombasophilicleukemiarbl2h3cells
AT alqubaisim controlledreleaseformulationofantihistaminebasedoncetirizinezinclayeredhydroxidenanocompositesanditseffectonhistaminereleasefrombasophilicleukemiarbl2h3cells
AT husseinmz controlledreleaseformulationofantihistaminebasedoncetirizinezinclayeredhydroxidenanocompositesanditseffectonhistaminereleasefrombasophilicleukemiarbl2h3cells
AT ismailm controlledreleaseformulationofantihistaminebasedoncetirizinezinclayeredhydroxidenanocompositesanditseffectonhistaminereleasefrombasophilicleukemiarbl2h3cells
AT zainalz controlledreleaseformulationofantihistaminebasedoncetirizinezinclayeredhydroxidenanocompositesanditseffectonhistaminereleasefrombasophilicleukemiarbl2h3cells
AT hakimmn controlledreleaseformulationofantihistaminebasedoncetirizinezinclayeredhydroxidenanocompositesanditseffectonhistaminereleasefrombasophilicleukemiarbl2h3cells
_version_ 1718402907664023552